Luminex Announces Restructuring, Layoffs; Seeks Buyer for NeoPlex | GenomeWeb

NEW YORK (GenomeWeb News) – Luminex said after the close of the market Wednesday that it will undertake a restructuring that will result in an undisclosed number of employees being laid off and its Brisbane, Australia office being closed.

The Austin, Texas-based molecular diagnostics developer said that the restructuring will focus on its newborn screening group within its Assay and Related Products segment. In total, the firm expects to reduce its workforce by approximately 5 percent. It currently employs nearly 700 people.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.